Literature DB >> 12718831

The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression.

Adeel A Butt1, Stephanie Michaels, Patricia Kissinger.   

Abstract

BACKGROUND: The purpose of this study was to determine the association of serum lactate dehydrogenase (LDH) levels with certain opportunistic infection and to determine an association between LDH levels and CD4+ lymphocyte counts.
METHOD: We studied 352 patients retrospectively with HIV infection and one of the following infections: histoplasmosis; toxoplasmosis; tuberculosis (pulmonary and disseminated); bacterial pneumonia; Pneumocystis carinii pneumonia. Demographic and clinical data were obtained from the Adult Spectrum of Diseases (ASD) database in New Orleans. Bivariate and multivariate analysis were used to determine the association between LDH levels and opportunistic infections and CD4+ lymphocyte counts.
RESULTS: Patients with a serum LDH level <225 IU/L had a mean CD4+ lymphocyte count of 159/dl (SE 19.3) as compared to patients with a serum LDH level > or =225 IU/L, who had a mean CD4+ lymphocyte count of 58/dl (SE 6.9) (P<0.01). Non-Caucasian race, a diagnosis of histoplasmosis, disseminated tuberculosis or Pneumocystis carinii pneumonia, and CD4+ lymphocyte count were significantly associated with a serum LDH level > or =225 IU/L in the bivariate analysis. In a multivariate analysis, after controlling for race and CD4+ lymphocyte count, the only diagnoses that were significantly associated with the serum LDH level were definitive Pneumocystis carinii pneumonia and toxoplasmosis. Having a higher LDH level was not associated with early mortality.
CONCLUSIONS: Although not diagnostic, serum LDH levels could be used as an adjunctive marker in certain opportunistic infections. There is an inverse relationship between serum LDH levels and CD4+ lymphocyte counts in this group.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12718831     DOI: 10.1016/s1201-9712(02)90107-4

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  11 in total

1.  Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.

Authors:  Sejal Morjaria; John Frame; Alexandra Franco-Garcia; Alexander Geyer; Mini Kamboj; N Esther Babady
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

3.  Disseminated histoplasmosis in an HIV patient with CD4 count of 1 cell/µL.

Authors:  Sri Harsha Tella; Ahmed Abuzaid
Journal:  BMJ Case Rep       Date:  2014-08-19

4.  Identification of fatigue biomarkers in treated and treatment-naive HIV patients: preliminary results.

Authors:  Kelly Jensen; Young Ah Goo; Anella Yahiaoui; Sundeep Bajwa; Dave Goodlett; Jim Russo; Joachim Voss
Journal:  Biol Res Nurs       Date:  2013-07-16       Impact factor: 2.522

5.  Inactivation of the transcription factor GLI1 accelerates pancreatic cancer progression.

Authors:  Lisa D Mills; Lizhi Zhang; Ronald Marler; Phyllis Svingen; Maite G Fernandez-Barrena; Maneesh Dave; William Bamlet; Robert R McWilliams; Gloria M Petersen; William Faubion; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

Review 6.  Clinical review: Respiratory failure in HIV-infected patients--a changing picture.

Authors:  Putul Sarkar; Husham F Rasheed
Journal:  Crit Care       Date:  2013-06-14       Impact factor: 9.097

7.  Covariate random effects on the CD4 count variation during HIV disease progression in women.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  HIV AIDS (Auckl)       Date:  2019-05-20

8.  An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.

Authors:  Partson Tinarwo; Temesgen Zewotir; Nonhlanhla Yende-Zuma; Nigel J Garrett; Delia North
Journal:  Infect Dis Ther       Date:  2019-02-12

9.  Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy.

Authors:  Lie Yang; Peng Xia; Yangzhong Zhou; Quexuan Cui; Gang Chen; Ke Zheng; Yan Qin; Xuemei Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-05-28       Impact factor: 3.267

10.  Trends and Adaptive Optimal Set Points of CD4+ Count Clinical Covariates at Each Phase of the HIV Disease Progression.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  AIDS Res Treat       Date:  2020-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.